New findings may help patients with low to moderate risk of tumor lysis syndrome while reducing the burden for hematologists.

A recently-filed class action lawsuit accuses a former pharmacist at University of Maryland Medical Center of hacked into ...

GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced a new e-commerce experience ...

Employee-owned Hy-Vee operates more than 570 business units across nine Midwestern states, with sales of $13 billion-plus ...

Amid growing legislative pressures and industry debates, pharmacy benefit managers (PBMs) are exploring new strategies to ...

Over the years, there have been significant changes to the dyslipidemia medication management guidelines, alongside ...

Rutgers Health researchers have developed an oral antiviral drug candidate for COVID-19 that could overcome major limitations of Paxlovid, currently the most prescribed oral treatment.

A study published in Nature Chemistry by researchers from the University of Pittsburgh and Yale University shows how common ...

In what appears to be the near end of this year’s Idaho legislative session, Idaho Republican legislative leaders are backing ...

A summit will be held this month exploring the science of cannabis, its interaction with human genetics and how personalised ...

People on TikTok claim taking antihistamines like Pepcid AC and Zyrtec can help alleviate PMDD symptoms. Doctors explain ...

President Trump yesterday announced a baseline tariff of 10% on all imported products and higher rates on certain countries ...